Key result
Robotic-assisted hysterectomy is linked to ~78% fewer laparotomy conversions versus conventional laparoscopy for endometrial cancer.
Why the study?
Does robotic-assisted hysterectomy reduce laparotomy conversion, unplanned readmission, and perioperative mortality compared to conventional laparoscopic hysterectomy in patients with stage I-III endometrial cancer?
Does robotic-assisted hysterectomy reduce laparotomy conversion, unplanned readmission, and perioperative mortality compared to conventional laparoscopic hysterectomy in patients with stage I-III endometrial cancer?
Robotic-assisted hysterectomy for stage I-III endometrial cancer is associated with significantly lower rates of laparotomy conversion, unplanned readmission, and perioperative mortality compared to conventional laparoscopic hysterectomy.
Answers are grounded in this paper and cite their sources.
Although observational data suggests potential differences in conversion rates between robotic and laparoscopic approaches; leaves open whether these findings.
BACKGROUND Conversion to laparotomy during minimally invasive hysterectomy for endometrial cancer has been an active area of research interest. Such data are scarce within a more contemporary study period. OBJECTIVE The primary objective was to compare laparotomy conversion rates between robotic-assisted and conventional laparoscopic hysterectomy for endometrial cancer; the secondary objective was to assess unplanned readmission and perioperative mortality per surgical modality. STUDY DESIGN This comparative effectiveness study queried the Commission-on-Cancer's National Cancer Database. The study population included 210,615 patients with stage I-III endometrial cancer who underwent upfront minimally invasive hysterectomy from 2012 to 2023. Exposure was intent-level surgical modality comparing robotic-assisted and conventional laparoscopic hysterectomy (n=164,137 and n=46,478, respectively). The primary outcome measure was laparotomy conversion, defined as open surgery at the per-procedure level; the secondary outcome measures included unplanned post-discharge readmission and perioperative mortality within 30 days of the index anti-cancer surgery. Temporal trends were assessed with linear segment regression model. The exposure-outcome association was assessed in propensity score inverse probability of treatment weighting cohort to reduce the differences in baseline clinico-pathological characteristics between the two surgical modality groups, created with a multivariable generalized linear model with Poisson distribution. A classification-tree was constructed to visualize the patterns of clinico-pathological characteristics associated with laparotomy conversion. RESULTS Over the 12-year study period, laparotomy conversion rates decreased from 2.1% to 1.0% in the robotic-assisted hysterectomy group (average annual percentage change -5.1%, 95% confidence interval [CI] -7.6% to -3.1%) and from 9.0% to 4.8% in the conventional laparoscopic hysterectomy group (average annual percentage change -6.1%, 95%Cl -7.3% to -4.9%). Larger tumor size was associated with higher laparotomy conversion rate for both surgical modalities: inflection points for increasing laparotomy conversion rates were 5 cm and 4 cm for robotic-assisted and conventional laparoscopic surgery, respectively. In the weighted model, robotic-assisted hysterectomy was associated with a 78% lower laparotomy conversion rate compared to conventional laparoscopic hysterectomy (1.5% vs 6.3%, incidence rate ratio [IRR] 0.22, 95%CI 0.21 to 0.24). Unplanned readmission (16.9 vs 19.0 per 1,000, IRR 0.89, 95%Cl 0.83 to 0.96) and perioperative mortality (2.0 vs 2.6 per 1,000, IRR 0.80, 95%Cl 0.65 to 0.99) rates were also lower for robotic-assisted hysterectomy compared to conventional laparoscopic hysterectomy. A classification-tree identified 20 unique clinico-pathological patterns associated with laparotomy conversion, of which three patterns exceeded 10%. All three patterns had conventional laparoscopic hysterectomy for tumor size of 6 cm or greater, whereas robotic-assisted surgery for tumor size of smaller than 4 cm had a rate of 1% or less. CONCLUSION The results of this study suggested that among the Commission-on-Cancer-affiliated hospitals in the United States, laparotomy conversion during minimally invasive hysterectomy for endometrial cancer has decreased. While limited by potential confounding by surgeon- or patient-related factors, these data suggest that surgeons who preferentially perform robotic-assisted hysterectomy may have associated lower rates of laparotomy conversion, unplanned post-discharge readmission, and perioperative mortality compared to those who perform conventional laparoscopic hysterectomy. Whether perioperative morbidity differs by a surgeon's preferred practice for minimally invasive surgery warrants further evaluation.
No takes yet. Share an insight, caveat, or question.
Keymeulen et al. (2026) studied this question. Robotic-assisted hysterectomy was associated with a 78% lower laparotomy conversion rate compared to conventional laparoscopic hysterectomy for endometrial cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: